Understand gout treatment options: A clinical guide to flare relief and long-term control

Two goals of gout treatment

Gout treatment has two distinct objectives: ending the inflammation and pain of an acute flare, and reducing the body’s urate burden over time. Gout occurs when monosodium urate crystals accumulate in tissues, commonly producing sudden pain, swelling, redness, and tenderness in the big toe, although knees, ankles, feet, hands, wrists, and elbows can also be affected. Long-term control depends on lowering serum urate below the level at which crystals persist, rather than treating pain alone. 1

A flare may peak within 12 to 24 hours and can eventually settle without treatment, but repeated untreated attacks may affect more joints, last longer, and become increasingly severe. Persistent crystal deposits can form tophi, which are firm masses in soft tissue or bone around joints. These complications explain why recurrent attacks, tophi, joint damage, kidney disease, or certain kidney-stone risks may justify preventive urate-lowering treatment. 3

Medicines for an acute flare

Common first-line options for an acute attack are a nonsteroidal anti-inflammatory drug, colchicine, or a glucocorticoid. The appropriate choice depends on factors such as kidney function, other medical conditions, potential drug interactions, the number of joints involved, and the severity of inflammation. Colchicine generally works best when taken early in a flare, while corticosteroids may be considered when other anti-inflammatory medicines are unsuitable or ineffective. 2

NSAIDs can reduce pain and inflammation but may require caution in people with kidney disease, gastrointestinal risks, cardiovascular conditions, or interacting medicines. Colchicine also has important dosing and interaction considerations, particularly when kidney or liver function is impaired. Glucocorticoids may be given orally or by injection depending on the clinical circumstances. A healthcare professional should distinguish gout from infection, injury, or calcium pyrophosphate deposition disease when the presentation is uncertain. 10

Long-term urate-lowering therapy

Urate-lowering therapy is aimed at preventing future flares and reducing the accumulated crystal burden. Allopurinol is generally the preferred first-line medicine, including for many people with chronic kidney disease. It is usually started at a low dose and gradually increased while serum urate and treatment tolerance are monitored. The commonly used treatment target is a serum urate level below 6 mg/dL, with a lower target sometimes considered for severe tophaceous gout. 10

Febuxostat is another medicine that lowers uric acid production and may be considered when allopurinol is not tolerated, is unsuitable, or does not achieve the treatment goal. Probenecid and related uricosuric approaches increase uric acid excretion through the kidneys, but they may be unsuitable for people with certain kidney problems or a history of uric-acid kidney stones. Medication selection must account for kidney function, comorbidities, other prescriptions, and the individual response to treatment. 8

Preventing flares when therapy begins

Starting urate-lowering therapy can temporarily provoke a gout flare as stored urate changes and crystals begin to destabilize. For that reason, clinicians often prescribe anti-inflammatory prophylaxis during the early phase of treatment. Colchicine, an NSAID, or a low-dose corticosteroid may be used, commonly for at least three to six months, depending on flare activity, tophi, treatment response, and safety factors. 10

Preventive therapy does not replace urate lowering. Medicines that control acute inflammation can shorten or ease an attack, but they do not remove the underlying excess urate burden. Long-term management therefore involves continued adherence, gradual dose adjustment when indicated, and periodic serum urate monitoring. A flare after treatment begins does not necessarily mean the urate-lowering medicine has failed, although persistent attacks should prompt clinical review. 6

Lifestyle measures and daily management

Lifestyle changes can support medication-based treatment. Research and clinical guidance identify limiting alcohol, especially binge drinking, reducing sugar-sweetened drinks and high-fructose products, managing excess weight, and avoiding dehydration as useful measures. Foods associated with higher purine exposure include organ meats, some red meats, certain seafoods, and anchovies. Dietary changes may reduce risk and support overall health, but they usually do not substitute for urate-lowering medicine when recurrent or complicated gout makes that therapy appropriate. 3

During a flare, rest, local cooling, and protecting the painful joint may complement prescribed medication. Symptoms can worsen when treatment is delayed, and a treated episode may last one or two days instead of six or seven, although severe flares can take up to 14 days to resolve completely. There is no rapid home cure that permanently eliminates gout. Recurrent symptoms, unusual joint involvement, fever, or uncertainty about the diagnosis require medical assessment. 9

Safety, diagnosis, and specialist options

Allopurinol can rarely cause severe hypersensitivity reactions. People of Southeast Asian or African American ancestry may be advised to undergo HLA-B*5801 testing before starting it because this allele is associated with increased risk. Any new widespread rash, blistering, mucosal symptoms, facial swelling, or serious illness after starting a medicine warrants urgent medical attention. Drug choices also require review of kidney function, liver considerations, cardiovascular history, and possible interactions. 1

When the diagnosis is uncertain, analysis of joint fluid showing monosodium urate crystals is considered definitive. If standard urate-lowering medicines fail to control severe disease, pegloticase, an intravenous therapy, is generally reserved for severe, refractory gout under specialist supervision. Such treatment involves ongoing monitoring and is not a routine first step. Effective care therefore combines diagnostic confirmation when needed, prompt flare treatment, a serum urate target, prophylaxis during treatment initiation, and long-term follow-up. 7

Sources

1. NCBI Bookshelf, StatPearls: Gout
2. Cleveland Clinic, Gout: What It Is, Symptoms & Treatment
3. Arthritis Foundation, Gout: Symptoms, Diagnosis, and Treatment
4. Harvard Health, Gout: A to Z
5. Medscape, Gout and Pseudogout Treatment & Management
6. Healio Clinical Guidance, Pharmacologic Urate-Lowering Therapy
7. Healio Clinical Guidance, Comprehensive Disease-Management Plan
8. MedlinePlus, Gout
9. Cleveland Clinic Health Essentials, Gout Self-Care
10. American College of Rheumatology Guideline, PubMed indexed summary